Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Issue Archive

Table of Contents

BLOOD ADVANCES TALK

DRUG ADVANCES

STIMULUS REPORT

REVIEW ARTICLE

CLINICAL TRIALS AND OBSERVATIONS

HEALTH SERVICES AND OUTCOMES

Kristina Stojkov,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Tobias Silzle,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Georg Stussi,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),David Schwappach,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Juerg Bernhard,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),David Bowen,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Jaroslav Čermák,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Avinash G. Dinmohamed,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Corien Eeltink,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Sabrina Eggmann,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Pierre Fenaux,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Ulrich Germing,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Manuel Haschke,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Eva Hellstrom-Lindberg,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Monika Heger,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Arjan A. van de Loosdrecht,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Jakob Passweg,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Michael Pfeilstöcker,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Uwe Platzbecker,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Luca Malcovati,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),António Medina de Almeida,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Moshe Mittelman,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Christine Morgenthaler,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),David P. Steensma,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Valeria Santini,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Reinhard Stauder,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Argiris Symeonidis,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Sämi Schär,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Charlotte Maddox,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Theo de Witte,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Julia Bohlius,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK),Nicolas Bonadies,on behalf of the Swiss MDS Study Group and the Swiss Group of Clinical Cancer Research (SAKK)

IMMUNOBIOLOGY AND IMMUNOTHERAPY

LYMPHOID NEOPLASIA

MYELOID NEOPLASIA

RED CELLS, IRON, AND ERYTHROPOIESIS

TRANSFUSION MEDICINE

TRANSPLANTATION

COMMENTARY

ERRATUM

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals